The ROE as of November 2024 (TTM) for Silo Pharma, Inc. (SILO) is -56.41%

According to Silo Pharma, Inc.’s latest financial reports and current stock price. The company's current ROE is -56.41%. This represents a change of 290.75% compared to the average of -14.44% of the last 4 quarters.

Silo Pharma, Inc. (SILO) Historical ROE (quarterly & annually)

How has SILO ROE performed in the past?

The mean historical ROE of Silo Pharma, Inc. over the last ten years is 390.28%. The current -56.41% ROE has changed -114.45% with respect to the historical average. Over the past ten years (40 quarters), SILO's ROE was at its highest in in the December 2019 quarter at 1.67%. The ROE was at its lowest in in the June 2019 quarter at -235.28%.

Silo Pharma, Inc. (SILO) ROE by Quarter and Year

Discovering the peaks and valleys of Silo Pharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Silo Pharma, Inc. (SILO) Average ROE

How has SILO ROE performed in the past?

The current ROE of Silo Pharma, Inc. (SILO) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Silo Pharma, Inc. (SILO) ROE vs. Peers

How is SILO’s ROE compared to its peers?

Silo Pharma, Inc.’s ROE is greater than Protagenic Therapeutics, Inc. (-238.37%), greater than Rezolute, Inc. (-70.73%), greater than Lumos Pharma, Inc. (-157.99%), greater than Anebulo Pharmaceuticals, Inc. (-138.92%), less than Sino Biopharmaceutical Limited (1.69%), less than Inventiva S.A. (550.46%), less than BioCardia, Inc. (526.79%), less than UroGen Pharma Ltd. (388.24%), greater than Indaptus Therapeutics, Inc. (-146.70%), greater than Tempest Therapeutics, Inc. (-201.10%), less than Comera Life Sciences Holdings, Inc. (67.46%), greater than Forte Biosciences, Inc. (-117.85%), greater than Pardes Biosciences, Inc. (-54.84%), greater than Shattuck Labs, Inc. (-68.65%), greater than Eliem Therapeutics, Inc. (-47.03%), less than Champions Oncology, Inc. (323.52%), greater than Century Therapeutics, Inc. (-65.37%), greater than Acumen Pharmaceuticals, Inc. (-24.63%), greater than HOOKIPA Pharma Inc. (-51.77%), greater than Day One Biopharmaceuticals, Inc. (-22.40%), greater than Inozyme Pharma, Inc. (-68.93%), greater than Terns Pharmaceuticals, Inc. (-39.58%),

Build a custom stock screener for Silo Pharma, Inc. (SILO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Silo Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Silo Pharma, Inc. (SILO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Silo Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.